
OPTIPATH combines forefront expertise within pathology, MEMS, nano-photonics, bio-photonics, nanofabrication and towards opening a new frontier in pathology. With partners from Norway, Denmark, Finland and the United Kingdom.
Partners

SINTEF
SINTEF coordinates OPTIPATH and leads the technology development of MEMS-metasurface components, as well as the exploitation activities related to both the developed miniscope system and wider use-cases enabled by the technology.

University of Southern Denmark
The Centre for Nano Optics at the University of Southern Denmark is highly experienced in the design and fabrication of metasurfaces, and will conduct theoretical investigation, design, and proof-of-concept experimental verification of the MEMS-tunable metasurfaces.

University of Oslo and Oslo University Hospital
The Pahnke lab is specialized in different methods for tissue analysis from cellular via mouse models to patient material, and will provide technical, biological and specialist expertise in surgical pathology for this consortium in combination with the setting of a highly professional, routine surgical pathology diagnostics department.

NIL Technologies
NILT is an optical solutions SME designing, developing, and manufacturing optical elements and components using high-precision nanoscale features. In this project they will enable rapid prototyping, wafer-level integration and MEMS-metasurface assembly.

Aston University
Aston University is one of the largest photonics research centres in the UK, and Prof. Meglinski will be in charge of providing a theoretical framework for modelling of VVBs interaction with turbid tissue. This will be essential for designing the experimental systems and understanding the results.

University of Oulu
The University of Oulu has developed a novel digital histopathology tool that will be enhanced by the addition of the breakthrough OMS-MEMS devices to enable multidimensional pathology. The Biophotonics group in Oulu will be important in bridging the gap between the pathologists and the optical technology developers.
